European Commission approves expanded use of Merck's Keytruda in bladder cancer. Sanofi & Lilly announce data from phase III studies on pipeline...

FDA approves J&J's Tremfya for ulcerative colitis. NVO's oral obesity pill, amycretin, shows faster weight loss than weekly injection, Wegovy.

Eli Lilly stock boasts both defensive and growth characteristics

The FDA approves subcutaneous formulation of RHHBY's leading immunotherapy drug, Tecentriq, under the brand name Tecentriq Hybreza.

RHHBY's data on experimental obesity drug, CT-996, disappoints investors on higher incidence of adverse events.

INDIANAPOLIS, Sept. 13, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved...

The Justice, Peace and Development Commission (JPDC) of the Symposium of Episcopal Conferences of Africa and Madagascar (SECAM) (SECAM.org) is urging...

The Justice, Peace and Development Commission (JPDC) of the Symposium of Episcopal Conferences of Africa and Madagascar (SECAM) (SECAM.org) is urging...